What is more, the regulatory effects of lncRNA H19 on NF-κB signaling pathway have been excavated in various cancers, such as human osteosarcoma [38], gastric cancer [39], melanoma [40], and glioma [41]. This evidence concerns the gene NFKB1 and melanoma.